BSE Circulars (21045)
Bombay Stock Exchange circulars covering trading rules, listing requirements, compliance guidelines, market operations, and regulatory changes for market participants.
| Date | Circular | Tags | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSE notifies part redemption of bonds and payment of interest for Damodar Valley Corporation (DVC) with record date of 13 March 2026, … | |||||||||||||||
BSE notifies part redemption of bonds and payment of interest for Damodar Valley Corporation (DVC) with record date of 13 March 2026, resulting in reduced face value of Rs. 4,00,000 per bond effective the same date.
| |||||||||||||||
Damodar Valley Corporation has fixed a record date of 13 March 2026 for part redemption of bonds and payment of interest on two bond series … | |||||||||||||||
Damodar Valley Corporation has fixed a record date of 13 March 2026 for part redemption of bonds and payment of interest on two bond series (DVC-14A and DVC-14B), with reduced face value of Rs. 4,00,000 per bond effective the same date.
| |||||||||||||||
BSE notifies trading members of part redemption of non-convertible debentures and payment of interest by Bilaspur Pathrapali Road Private … | |||||||||||||||
BSE notifies trading members of part redemption of non-convertible debentures and payment of interest by Bilaspur Pathrapali Road Private Limited, with reduced face values effective March 13, 2026.
| |||||||||||||||
BSE notifies part redemption of non-convertible debentures and payment of interest for Bilaspur Pathrapali Road Private Limited, with record … | |||||||||||||||
BSE notifies part redemption of non-convertible debentures and payment of interest for Bilaspur Pathrapali Road Private Limited, with record date of 13 March 2026 and reduced face values effective the same date.
| |||||||||||||||
BSE notifies part redemption of non-convertible debentures and payment of interest for Bilaspur Pathrapali Road Private Limited, with record … | |||||||||||||||
BSE notifies part redemption of non-convertible debentures and payment of interest for Bilaspur Pathrapali Road Private Limited, with record date of 13 March 2026 and reduced face values effective the same date.
| |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to … | |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to show cause notice and non-existence at registered office address.
| |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to … | |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to show cause notice and confirmed non-existence at registered office address.
| |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to … | |||||||||||||||
BSE has prohibited/suspended trading in securities of Pradhin Limited (Scrip Code 530095) effective March 12, 2026, due to non-response to show cause notice and non-existence at registered office.
| |||||||||||||||
BSE notifies removal of PAN-India Drugs & Chemicals Limited from its Dissemination Board effective March 12, 2026, pursuant to SEBI circular … | |||||||||||||||
BSE notifies removal of PAN-India Drugs & Chemicals Limited from its Dissemination Board effective March 12, 2026, pursuant to SEBI circular on exclusively listed companies exercising exit option.
| |||||||||||||||
PAN-India Drugs & Chemicals Limited will be removed from the BSE Dissemination Board effective March 12, 2026, following the exit option … | |||||||||||||||
PAN-India Drugs & Chemicals Limited will be removed from the BSE Dissemination Board effective March 12, 2026, following the exit option exercised under SEBI circular SEBI/HO/MRD/DSA/CIR/P/2016/110.
| |||||||||||||||